HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazilian Blowout Sales May Be Squashed In California By Year-End

This article was originally published in The Rose Sheet

Executive Summary

The California attorney general files a motion in Los Angeles Superior Court claiming Brazilian Blowout maker GIB LLC is not honoring the terms of a January 2012 consent judgment, which requires the firm to stop selling its products in California if they emit volatile organic compounds in excess of state limits. Testing from three laboratories shows the company’s products to be in violation, but GIB wants greater clarification.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel